CenExel, CenExel ACT, CenExel JBR, Press Releases

RBG-admin _ July 22, 2021 _ 0 Comments

Heron Therapeutics Publication on ZYNRELEF™

Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™ SAN DIEGO, July 21, 2021 /PRNewswire/ — Heron

View More

CenExel, CenExel ACT, CenExel JBR, Press Releases

rumor _ May 13, 2021 _ 0 Comments

Heron Therapeutics Approval of ZYNRELEF™

Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours – ZYNRELEF is the first and only FDA-approved extended-release

View More